Our R&D technology innovation platform adheres to the concept of technology-driven innovation, providing customers with innovative solutions from the combination of synthesis, analysis, engineering and other aspects.

Our scientific and technological innovation field has expanded from traditional small molecule drugs to amino acids, peptides, PROTAC/ADC linkers, oligonucleotides, etc. Through the continuous development of new technologies, we accelerate the transformation of early clinical projects for customers.